Related Experiment Video
Updated: Dec 21, 2025

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic
Published on: September 4, 2012
Recurrent mastitis-persistent or new infections?
N Wente1, A S Grieger2, D Klocke2
1University of Applied Sciences and Arts Hannover, Faculty 2, Department of Bioprocess Engineering, Microbiology, 30453 Hanover, Germany; Animal Health and Animal Welfare, Faculty of Agricultural and Environmental Sciences, University of Rostock, 18051 Rostock, Germany.
Abstract:
Recurrent clinical mastitis contributes to around half of all infections having an economic impact in the dairy industry. It leads to milk yield reduction, increased risk of mortality, and culling, and may be caused by new infections or a persistent infection after previous treatment. Disease management is dependent on the infecting species, necessitating accurate identification of the pathogen in the range of persistent and reinfection cases among recurrent infections using culture and molecular biological analysis. Milk samples from diagnosed clinical mastitis cases were collected from three Northern German dairy farms between 2011 and 2015. Totally, 2043 diagnosed mastitis cases were examined at quarter level (1598 (78.2 %) first and 445 (21.8 %) recurrent mastitis cases in lactation). Among the recurrent cases, 145 (32.6 %) cases were confirmed to harbor the same pathogenic species as previous infections. RAPD PCR confirmed the same species strain in 49 (11 %) of the recurrent infections. The contribution of new infections as compared to persistent infections in cases of clinical mastitis is clear from the data. Future studies in recurrent clinical mastitis control should be focused on influencing factors to prevent new infections in addition to therapeutic intervention and bacteriological cure.
More Related Videos
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Tonsillitis II: Management
Endocarditis III: Medical Management
Stages of Infection
Acute Pyelonephritis II: Diagnostic Studies and Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

